EVENT

January 9, 2023 – January 12, 2023

KPMG at the 41st Annual J.P. Morgan Healthcare Conference 2023



This year KPMG will be hosting a series of events to coincide with the 41st Annual J.P. Morgan Healthcare Conference. Hear from leading industry luminaries, emerging fast-growth companies, innovative technology creators, and members of the investment community and get forward-thinking perspectives and insights on key life sciences and healthcare topics.

If you are planning on being in San Francisco for the J.P. Morgan Healthcare Conference, we want to see you!

Add KPMG to your agenda:

  • January 10, 2023 – Healthcare and Life Sciences Executive Roundtable: Join KPMG and healthcare industry leaders for an executive roundtable to discuss market themes, deal trends and outlook for 2023.
  • January 11, 2023 – Goodwin + KPMG @JPMorgan Symposium: Join KPMG, Goodwin, and other industry executives, as we dedicate an entire day to exploring ways life sciences companies can identify and accelerate their R&D programs, maximize value from licensing, M&A, and other transactions, and seize opportunities to raise capital without getting caught in a riptide.

Register for Tuesday, January 10 – Healthcare and Life Sciences Executive Roundtable

Register for Wednesday, January 11 – Goodwin + KPMG @ JPMorgan Symposium

Additional details on these events can be found below.

  • January 10-11, 2023

January 10-11, 2023

January 10, 2023 | Healthcare and Life Sciences Executive Roundtable

Join KPMG and healthcare industry leaders for an executive roundtable to discuss market themes, deal trends and outlook for 2023. 

Panelists include:

  • Ross Nelson, MD, Partner, HC Strategy Leader
  • Andrew Kaplan, Managing Director, Bain Capital
  • Andy Caselli, AVP, Corporate Development, CVS Health
  • Sami Yusuf, Chair of Corporate Development, Mayo Clinic
  • Bhawna Sapra, Head of Strategy, Molina Healthcare 
  • Brett Glover, Partner, HCLS Financial Deals Leader

….along with others from leading health systems and payors. Stay tuned for our additions!

After the session, we invite you to join us and your peers for a networking reception.

Date: Tuesday, January 10, 2023

Time: 3:30 p.m.–5:30 p.m.

Location: KPMG in San Francisco, 55 Second Street, 11th Floor, San Francisco, CA 94105

Register for Tuesday, January 10 – Healthcare and Life Sciences Executive Roundtable

Register for Wednesday, January 11 – Goodwin + KPMG @ JPMorgan Symposium


January 11, 2023 | Goodwin + KPMG @JPMorgan Symposium

Join KPMG and industry executives from private equity, payors and large health systems as they discuss macro deal trends and what to expect in 2023.

Date: Wednesday, January 11, 2023.

Time: 8:30 a.m.–5:00 p.m.

Location: InterContinental San Francisco

KPMG and Goodwin are pleased to invite you to our 4th Annual Symposium held during the 41st Annual J.P. Morgan Healthcare Conference week.

As the life sciences industry grapples with changing tides, there remains a wealth of opportunities for companies to come out ahead. During this year’s conference, you will hear from top strategy, legal and financial partners as they engage luminaries across the life sciences and healthcare industries to explore ways life sciences companies can identify and accelerate their R&D programs, maximize value from licensing, M&A, and other transactions, and seize opportunities to raise capital without getting caught in a riptide.

This year, we are pleased to welcome Pablo Legorreta, Founder and CEO of Royalty Pharma, who will deliver our keynote address!

Goodwin + KPMG @ JPMorgan Symposium

Full Agenda (all times Pacific)

WEDNESDAY, JANUARY 11
9:00 – 9:15 AM

WELCOME REMARKS

  • Mitch Bloom, Chair, Life Sciences and Partner, Goodwin
  • Kristin Ciriello Pothier, Global and US Leader, HCLS Deal Advisory and Strategy, KPMG (moderator)
9:15 – 9:30 AM
IGNITE TALK: HOT TOPICS IN 2023 AND BEYOND IN THE HEALTHCARE REGULATORY ENVIRONMENT
  • Matt Wetzel, Partner, Goodwin
9:30 – 10:00 AM

PANEL: AI COLLIDING WITH LIFE SCIENCES: FUNDRAISING, LEGAL, AND OTHER ISSUES WHEN INVESTING IN OR SELLING LIFE SCIENCE COMPANIES THAT INCORPORATE AI PLATFORMS

  • Olivia Uitto, Partner, Goodwin 
  • Jessica Lin, Healthcare and Life Sciences Deal Advisory and Strategy, KPMG (Moderator)
  • Duane Valz, General Counsel, insitro
  • Chris Scotto DiVetta, SVP and GM of AI, Tempus
10:00 – 10:45 AM

PANEL: EARLY-STAGE COMPANY: NUTS AND BOLTS OF BUILDING A START-UP AND DRIVING TO SUCCESSFUL FINANCING

  • Deepa Rich, Partner, Goodwin
  • Steve Sapletal, Partner, KPMG
  • John Boyce, Co-Founder & Managing Director, Tiger Gene Ventures
  • Galya Blachman, General Counsel and Chief Compliance Officer, COO, 4:59 Initiative at 5AM Ventures
  • Sally Wang Liang, JD, MPH, Venture Partner, Viva Bioinnovator
10:45 – 11:30 AM

PANEL: GLOBAL PRECISION MEDICINE

  • Kristin Ciriello Pothier, Global and US Leader, HCLS Deal Advisory and Strategy, KPMG 
  • Marc Stapley, CEO, Veracyte
  • Nicole Lambert, Chief Operating Officer, Myriad Genetics
  • Gitte Pedersen, CEO, Genomic Expression
  • Gabriele Allegri, Global Commercial Head - Precision Medicine, Janssen Pharmaceutical Companies of Johnson & Johnson
11:30 AM – 12:00 PM

PANEL: EXPLORING THE ECONOMINC AND LEGAL COMPLEXITIES OF IN SILICO RESEARCH AND DRUG DISCOVERY COLLABORATION AGREEMENTS

  • Lily Wound, Partner, Goodwin
  • Lynn Durham, Founder and CEO, Stalicla
  • Dr. Maria Luis Pineda, CEO and Co-Founder, Envisagenics
  • Carolina Aguilar, CEO and Co-Founder, INBRAIN
  • Michael McInerney ,Head of Digital Health Business Development, Bristol Myers Squibb
12:00 – 12:45 PM

 

KEYNOTE ADDRESS: PABLO LEGORETTA, FOUNDER AND CEO, ROYALTY PHARMA

 

12:45 – 1:30 PM

LUNCH

1:30 – 2:15 PM

PANEL: CURRENT TRENDS IN ROYALTY MONETIZATION 

  • Danielle Lauzon, Partner, Goodwin (Moderator)
  • Jaqueline Mercier, Partner, Goodwin
  • Art McGivern, GC, Royalty Pharma
  • Kris Ring, Partner, Goodwin 
  • Mike Landsittel, CFO, Blueprint
  • Yasha Dyatlovitsky, Managing Director of Capital Markets, Cowen
2:15 – 3:00 PM

FIRESIDE CHAT: THE EVOLVING FTC POLICY AND IMPLICATIONS OF THE DEAL LANDSCAPE

  • Arman Oruc, Goodwin
  • Stuart Cable, Vice Chairman, Global Chair of M&A, Goodwin
3:00 – 3:10 PM COFFEE BREAK
3:10 – 3:30 PM

 

IGNITE TALK: STATE OF THE CAPITAL MARKETS 

  • Sean MacGregor, Executive Director, Healthcare Investment, J.P. Morgan


3:30 – 4:15 PM

PANEL: STRATEGIES FOR RAISING CAPITAL IN THE CURRENT MARKET ENVIRONMENT AND GETTING IPO READY

  • Janet Lehman, Audit Partner, National VC Life Sciences Leader, KPMG (Moderator)
  • Sean MacGregor, Executive Director, Healthcare Investment, J.P. Morgan
  • Ben Marsh, Partner, Goodwin
  • Marc Dumaine, Partner, KPMG
  • Jennifer (Schutt) Ziolkowski, Chief Financial Officer, Vigil Neuroscience
4:15 – 5:00 PM

 

PANEL: STRATEGIES FOR ALTERNATIVE FINANCING FOR PRECOMMERCIAL PUBLIC COMPANIES

  • Shari Mager, Partner, U.S. Deal Advisory & Strategy National Capital Markets Readiness Leader, KPMG (Moderator)
  • Marianne Sarrazin, Partner, Goodwin
  • Rakhee Bhagat, Managing Director, William Blair
  • Peter GarcÍa, Chief Financial Officer, ALX Oncology
5:00 – 6:30 PM COCKTAILS & NETWORKING

Connect with our team

Kristin C. Pothier

Kristin C. Pothier

Global & National, HCLS Deal Advisory & Strategy Leader, KPMG US

+1 617 549 2779
Janet Lehman

Janet Lehman

Partner, Audit, U.S. Venture Capital Life Sciences Leader, KPMG US

Brett Glover

Brett Glover

National Financial Due Diligence and Deal Advisory Strategy Leader, Healthcare and Life Sciences, KPMG US

+1 214-840-8579
Jeff Stoll, PhD

Jeff Stoll, PhD

Principal, National Strategy Life Sciences Leader, KPMG US

+1 857-334-8768